To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine
Clinical trial NCT00207168 · COMPLETED
Trial details
- NCT number
- NCT00207168
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.